Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001902368-25-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 30, 2025 |
| Document Date | Dec 24, 2025 |
| Document | View SEC Filing |
Transactions
3
Total Shares
45,000
Total Value
$763,954.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Dec 24, 2025 | Exercise/Conversion | 15,000 | $8.93 | $133,950.00 | 103,787 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Dec 24, 2025 | Sale | 15,000 | $42.00 | $630,004.50 | 88,787 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Employee stock option (right to buy) | Derivative | Dec 24, 2025 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 76,000 | Direct | โ | View Details |